In recent years, medical breakthroughs including new drug therapies and early disease monitoring technologies have accelerated rapidly. This has created wide-ranging transformations in patient care. But, these life-changing medical developments often come with challenges.
To examine the current state of biopharmaceutical science, PhRMA recently kicked off an expert panel as part of an ongoing national dialogue on The New Era of Medicine.
Breakthroughs, challenges and the future of modern medicine are rapidly evolving. Stephen Elledge, professor of genetics at Harvard Medical School, Julie Wolf-Rodda, director of development at the Foundation for the National Institutes of Health and Daniel Skovronsky, senior vice president of clinical and product development at Eli Lilly and Company, sat down to discuss what this means for research and patient care.